Behavioral Neuroscience – News and Features

This article examines some of the latest advances in biomarker discovery in the fields of cancer and neurodegenerative and infectious diseases and the technologies that are driving these discoveries.

A phase 1/2 trial indicates that a new drug can address the cognitive difficulties associated with Down syndrome.

Caltech researchers found that humans think at 10 bits per second, far slower than the billion bits per second gathered by sensory systems. This limitation, rooted in evolutionary navigation systems, explains why we process one thought at a time.

A new study published in BMJ investigated whether occupations that engage specific brain regions more intensively could reduce the burden of AD.

Researchers found that accelerated biological aging, measured via DNA methylation, predicts frailty, cognitive decline, and dementia risk. Females experience memory loss, while males show slowed mental processing and nearly double the dementia risk.

Northwestern Medicine researchers found that breathing rhythms during sleep synchronize hippocampal brain waves critical for memory consolidation. Disordered breathing, like sleep apnea, may disrupt this process.

New research shows that body-weight control in mice is strongly modulated by neurons in the nucleus accumbens, a region of the brain that’s rich in endocannabinoids and that helps regulate food reward and physical activity.

Researchers have discovered a new genetic regulatory mechanism involved in behavioral adaptations to emotional experiences.

Targeting antidepressant medications to cells in the gut could not only be an effective treatment of mood disorders like depression and anxiety but may also cause fewer adverse side effects.

A new study uncovers the neurological mechanisms that influence how we form social connections, and how we learn from social rejection.